BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37023333)

  • 1. Lead Optimization of Androgen Receptor-HSP27 Disrupting Agents in Glioblastoma.
    Li Y; Orahoske C; Salem F; Johnson A; Tannous C; Devole L; Zhang W; Lathia JD; Wang B; Su B
    J Med Chem; 2023 Apr; 66(8):5567-5583. PubMed ID: 37023333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-Molecule HSP27 Inhibitor Abolishes Androgen Receptors in Glioblastoma.
    Li Y; Orahoske CM; Geldenhuys WJ; Bhattarai A; Sabbagh A; Bobba V; Salem FM; Zhang W; Shukla GC; Lathia JD; Wang B; Su B
    J Med Chem; 2021 Feb; 64(3):1570-1583. PubMed ID: 33523674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity.
    Zoubeidi A; Zardan A; Beraldi E; Fazli L; Sowery R; Rennie P; Nelson C; Gleave M
    Cancer Res; 2007 Nov; 67(21):10455-65. PubMed ID: 17974989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor and heat shock protein 27 co-regulate the malignant potential of molecular apocrine breast cancer.
    Liu X; Feng C; Liu J; Cao L; Xiang G; Liu F; Wang S; Jiao J; Niu Y
    J Exp Clin Cancer Res; 2018 Apr; 37(1):90. PubMed ID: 29699584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane-associated androgen receptor (AR) potentiates its transcriptional activities by activating heat shock protein 27 (HSP27).
    Li J; Fu X; Cao S; Li J; Xing S; Li D; Dong Y; Cardin D; Park HW; Mauvais-Jarvis F; Zhang H
    J Biol Chem; 2018 Aug; 293(33):12719-12729. PubMed ID: 29934310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the heat shock protein HSP27 on androgen receptor expression and function in prostate cancer cells.
    Stope MB; Schubert T; Staar D; Rönnau C; Streitbörger A; Kroeger N; Kubisch C; Zimmermann U; Walther R; Burchardt M
    World J Urol; 2012 Jun; 30(3):327-31. PubMed ID: 22362414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The heat shock protein 70 inhibitor VER155008 suppresses the expression of HSP27, HOP and HSP90β and the androgen receptor, induces apoptosis, and attenuates prostate cancer cell growth.
    Brünnert D; Langer C; Zimmermann L; Bargou RC; Burchardt M; Chatterjee M; Stope MB
    J Cell Biochem; 2020 Jan; 121(1):407-417. PubMed ID: 31222811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up
    Wang M; Wang X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 47(1):72-78. PubMed ID: 35545365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HSP27 knockdown produces synergistic induction of apoptosis by HSP90 and kinase inhibitors in glioblastoma multiforme.
    Belkacemi L; Hebb MO
    Anticancer Res; 2014 Sep; 34(9):4915-27. PubMed ID: 25202074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancer.
    Lamoureux F; Thomas C; Yin MJ; Fazli L; Zoubeidi A; Gleave ME
    Eur Urol; 2014 Jul; 66(1):145-55. PubMed ID: 24411988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delineation of crosstalk between HSP27 and MMP-2/MMP-9: A synergistic therapeutic avenue for glioblastoma management.
    Rajesh Y; Banerjee A; Pal I; Biswas A; Das S; Dey KK; Kapoor N; Ghosh AK; Mitra P; Mandal M
    Biochim Biophys Acta Gen Subj; 2019 Jul; 1863(7):1196-1209. PubMed ID: 31028823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine prostate cancer (NEPCa) increased the neighboring PCa chemoresistance via altering the PTHrP/p38/Hsp27/androgen receptor (AR)/p21 signals.
    Cui Y; Sun Y; Hu S; Luo J; Li L; Li X; Yeh S; Jin J; Chang C
    Oncogene; 2016 Nov; 35(47):6065-6076. PubMed ID: 27375022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor (AR) inhibitor ErbB3-binding protein-1 (Ebp1) is not targeted by the newly identified AR controlling signaling axis heat-shock protein HSP27 and microRNA miR-1 in prostate cancer cells.
    Stope MB; Peters S; Großebrummel H; Zimmermann U; Walther R; Burchardt M
    World J Urol; 2015 Mar; 33(3):323-7. PubMed ID: 24798454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of androgen receptor expression with small interfering RNA enhances cancer cell apoptosis by suppressing survival factors in androgen insensitive, late stage LNCaP cells.
    Kim SS; Cho HJ; Kang JY; Kang HK; Yoo TK
    ScientificWorldJournal; 2013; 2013():519397. PubMed ID: 23476140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in HSP27 and HSP90-targeting strategies for glioblastoma.
    van Ommeren R; Staudt MD; Xu H; Hebb MO
    J Neurooncol; 2016 Apr; 127(2):209-19. PubMed ID: 26842818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor (AR) expression is an independent unfavorable prognostic factor in gastric cancer.
    Kominea A; Konstantinopoulos PA; Kapranos N; Vandoros G; Gkermpesi M; Andricopoulos P; Artelaris S; Savva S; Varakis I; Sotiropoulou-Bonikou G; Papavassiliou AG
    J Cancer Res Clin Oncol; 2004 May; 130(5):253-8. PubMed ID: 14963700
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Kim SY; Park JE; Lee HJ; Sim DY; Ahn CH; Park SY; Shim BS; Kim B; Lee DY; Kim SH
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor signaling regulates growth of glioblastoma multiforme in men.
    Yu X; Jiang Y; Wei W; Cong P; Ding Y; Xiang L; Wu K
    Tumour Biol; 2015 Feb; 36(2):967-72. PubMed ID: 25315188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen Receptor Expression in the Various Regions of Resected Glioblastoma Multiforme Tumors and in an In Vitro Model.
    Simińska D; Korbecki J; Kojder K; Jeżewski D; Tarnowski M; Tomasiak P; Piotrowska K; Masztalewicz M; Kolasa A; Chlubek D; Baranowska-Bosiacka I
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E.
    Andrieu C; Taieb D; Baylot V; Ettinger S; Soubeyran P; De-Thonel A; Nelson C; Garrido C; So A; Fazli L; Bladou F; Gleave M; Iovanna JL; Rocchi P
    Oncogene; 2010 Apr; 29(13):1883-96. PubMed ID: 20101233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.